Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children [Phase 4]
Phase 4 study of a new formulation of the DTPa-HBV-IPV/Hib vaccine as a booster in children aged 18-23 months; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines [Phase 3]
Phase 3 clinical trial update of a pneumococcal vaccine booster in healthy children 11-18 months previously primed with the same vaccines; s…
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: Post Market Surveillance for Infanrix™
Post-market surveillance study for Infanrix evaluated safety in diphtheria, acellular pertussis, and tetanus; results posted in 2009 after c…
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) [Phase 3]
Phase 3 trial evaluating the safety of administering Gardasil concurrently with a combined Diphtheria/Tetanus/Pertussis vaccine and a Mening…
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
Clinical trial update on Seroimmunity 2007 and a sub-study of the Swedish population assessing seroprevalence for vaccine-preventable diseas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine [Phase 4]
Phase IV study evaluating interchangeability of a liquid pentavalent combination vaccine for diphtheria, tetanus, pertussis, hepatitis B, an…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine [Phase 4]
Phase 4 safety and immunogenicity assessment of a liquid pentavalent DTP-HepB-Hib vaccine completed.
-
CLINICAL_TRIALS trial_result · 2009-06-08Clinical Trial Update: Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan [Phase 3]
Phase 3 trial in Taiwan evaluating immunogenicity and safety of a fifth dose of ADACEL (diphtheria-tetanus-pertussis vaccine); study complet…
-
CLINICAL_TRIALS trial_result · 2009-05-06Clinical Trial Update: Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine [Phase 4]
This Phase 4 trial reports on long-term safety, immunogenicity, and lot-to-lot consistency for a liquid pentavalent vaccine covering diphthe…
-
EMA withdrawal · 2008-09-10EMA Withdrawn: Quintanrix (Diphtheria toxoid;tetanus toxoid;inactivated Bordetella pertussis;hepatitis B surface antigen (rDNA);Haemophilus influenzae type b polysaccharide) — GlaxoSmithKline Biologicals S.A.
Quintanrix has been withdrawn from the market by GlaxoSmithKline Biologicals S.A., with the status indicating withdrawal for its diphtheria,…
-
CLINICAL_TRIALS trial_result · 2007-08-09Clinical Trial Update: Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine [Phase 4]
A Phase 4 trial assessing the immunogenicity and safety of a fifth booster dose of the diphtheria-tetanus-pertussis-polio vaccine. The study…
-
CLINICAL_TRIALS trial_result · 2006-12-08Clinical Trial Update: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants [Phase 2]
Phase 2 trial assessing immune response in infants after primary vaccination with Tritanrix-HepB mixed with three Hib-MenAC vaccine formulat…